preview

Essay on The Leadership and Management Development Program

Satisfactory Essays

Topic: You are the Corporate Learning and Organisational Development Manager of a global Pharmaceutical Company engaged in the development, manufacture and distribution of generic pharmaceuticals with commercials markets in the USA, Europe and Asia. The company is expanding into emerging markets and to sustain its rapid growth the organisation has recognised the need for strong leadership and management.

You have been asked to develop a leadership and management development programme for the top 30 managers across the globe. Drawing upon models and frameworks you have been taught, your personal reflection logs, discussion in action learning groups and formative assessments.

Identify and justify the key features and underpinning …show more content…

Respecting each other
They aim to incorporate these values into their employees’ everyday working lives and entrench the associated behaviours in the Medilax Group culture.
Their objectives are:
Grow in Emerging Markets
Find new opportunities for established products
Instill culture of innovation and continuous improvement
Invest in complimentary businesses

Their main strategy is moving their operations into more and more countries with the expansion of the company by purchasing new assets, including new businesses and develop new products. They aim to manage growth through strategic acquisitions. Their competitive advantage is differentiation that they adjust the size and amount of their products according to their customers’ need and budget.
Medilax Group is now one of the leading brands in Europe and throughout its history they put their signature on many important works. Recently they have encountered with some issues.

Current key issues
Medilax group have commercial markets in the USA, Europe and Asia and they are expanding into the emerging markets. In today’s medical industry, pharmaceutical companies face many challenges in a complex environment. Some of them are:
Continuing government pressure from USA and Asia to decrease prescription medicine prices.
Continuous effect of 2012’s economic recession.
As a part of Improvement and Modernization Act of 2006, Medicare Prescription had broader coverage Europe

Get Access